Cargando…

SARS-CoV-2-induced senescence as a potential therapeutic target

Long implicated in the pathology of ageing, cancer and many other systemic diseases, cellular senescence is now emerging as a key factor in the pathogenesis of severe COVID-19, with implications for other viral illnesses. https://bit.ly/3bbmOuT

Detalles Bibliográficos
Autores principales:	Denholm, Mary, Rintoul, Robert C., Muñoz-Espín, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248175/ https://www.ncbi.nlm.nih.gov/pubmed/35777777 http://dx.doi.org/10.1183/13993003.01101-2022

Ejemplares similares

Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence
por: Lin, Liangyu, et al.
Publicado: (2022)

Potential Therapeutic Target and Vaccines for SARS-CoV-2
por: Hussain, Mohamed A., et al.
Publicado: (2023)

Antibodies and SARS-CoV-2: New Data on Diagnostics and Therapeutics
por: Focosi, Daniele, et al.
Publicado: (2022)

Therapeutic potential of compounds targeting SARS-CoV-2 helicase
por: Halma, Matthew T. J., et al.
Publicado: (2022)

Potential Anti-SARS-CoV-2 Molecular Strategies
por: Vicidomini, Caterina, et al.
Publicado: (2023)

Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer
por: de Paula, Bruno, et al.
Publicado: (2023)

Nebulization: A potential source of SARS-CoV-2 transmission
por: Reychler, G., et al.
Publicado: (2020)

Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2
por: Zhou, Hong, et al.
Publicado: (2020)

Potential drug targets of SARS-CoV-2: From genomics to therapeutics
por: Shamsi, Anas, et al.
Publicado: (2021)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

SARS-CoV-2 docet
por: Sarli, Leopoldo
Publicado: (2021)

Integrins as Therapeutic Targets for SARS-CoV-2
por: Gressett, Timothy E., et al.
Publicado: (2022)

Updates in Management of SARS-CoV-2 Infection
por: Flisiak, Robert, et al.
Publicado: (2022)

Targeting senescent cells in translational medicine
por: Paez‐Ribes, Marta, et al.
Publicado: (2019)

Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents
por: Ayaz, Sameer, et al.
Publicado: (2020)

Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
por: de Marco, Ario, et al.
Publicado: (2022)

Potential Immunoregulatory and Antiviral/SARS-CoV-2 Activities of Nitric Oxide
por: Stefano, George B., et al.
Publicado: (2020)

Realising the potential of SARS-CoV-2 vaccines—a long shot?
por: The Lancet Respiratory Medicine
Publicado: (2021)

Autophagy and SARS-CoV-2 infection: A possible smart targeting of the autophagy pathway
por: Shojaei, Shahla, et al.
Publicado: (2020)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

SARS-CoV-2 Infection Causes Dopaminergic Neuron Senescence
por: Han, Yuling, et al.
Publicado: (2021)

Is the Patient Infected with SARS-CoV-2?
por: Klausner, Jeffrey D., et al.
Publicado: (2021)

Fundamentals of SARS-CoV-2 Biosensors
por: Torres-Torres, Carlos, et al.
Publicado: (2022)

Terrific cells for SARS-CoV-2
por: Gottschalk, Stephen
Publicado: (2022)

Can SARS-CoV-2 trigger reactive arthritis?
por: Wendling, Daniel, et al.
Publicado: (2021)

An intranasal ASO therapeutic targeting SARS-CoV-2
por: Zhu, Chi, et al.
Publicado: (2022)

Potential therapeutic and pharmacological strategies for SARS-CoV2
por: Ghareeb, Doaa A., et al.
Publicado: (2021)

Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
por: Zhou, Hong, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021)

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
por: Wu, Canrong, et al.
Publicado: (2020)

Viroinformatics-Based Analysis of SARS-CoV-2 Core Proteins for Potential Therapeutic Targets
por: Agrawal, Lokesh, et al.
Publicado: (2021)

Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
por: Policard, Martine, et al.
Publicado: (2021)

Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
por: Policard, Martine, et al.
Publicado: (2021)

Direct SARS-CoV-2 infection of the heart potentiates the cardiovascular sequelae of COVID-19
por: Bose, Rajendran J.C., et al.
Publicado: (2020)

SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse
por: Huang, Hongyan, et al.
Publicado: (2021)

SARS-CoV-2 vaccines: Potential refinements through induction of mucosal and trained immunity
por: Portilho, Amanda Izeli, et al.
Publicado: (2022)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
por: Trigueiro-Louro, João, et al.
Publicado: (2020)

Music of Microbiota Against SARS CoV-2
por: Belojevic, Goran, et al.
Publicado: (2019)

Focus on SARS-CoV-2 and COVID-19
por: Chen, Sharon C-A., et al.
Publicado: (2020)

In Pursuit of a SARS-CoV-2 Vaccine
por: Johnson, Alton R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bur2k5pukdjtlrj9ms4ems9isb